Roche
Avastin fails in colon cancer study
April 30, 2009Research and Development Cancer, Roche
Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …
Avastin helps Roche outpace the market again
April 16, 2009Sales and Marketing Roche
Strong sales growth across all its business divisions, including prescription medicines has helped Roche outpace the market again in the …
Roche lines up manufacturing and R&D reshuffle
April 1, 2009Sales and Marketing Genentech, Roche
Genentech's decision to succumb to Roche's $48.8 billion merger bid has signalled a revamp of manufacturing, R&D and other divisions …
Roche buys out Genentech with increased bid
March 12, 2009Sales and Marketing MA, Roche
Roche has finally struck a deal to acquire Genentech after raising its cash offer, putting an end to a prolonged …
Genentech urges shareholders to reject Roche bid
February 24, 2009Sales and Marketing Genentech, Roche
The battle for the future of Genentech has heated up after the company's board asked its shareholders to reject Roche's …
Roche rejoins ABPI after six-month suspension
February 23, 2009Sales and Marketing Code of Practice, Roche
Roche has been allowed to rejoin the ranks of the ABPI, after its six-month suspension for bringing discredit on the …
Positive results halt Avastin-Tarceva trial
February 16, 2009Sales and Marketing Cancer, Roche, avastin
A phase III trial has been stopped early after promising results for Avastin and Tarceva combined as first-line maintenance treatment …
Roche hit by strong Swiss franc
February 10, 2009Sales and Marketing Roche
Roche delivered solid performance in 2008, but was unable to shake off the negative effect of a strong Swiss franc. …
Roche bid for Genentech turns ‘hostile’ – but stays friendly
February 10, 2009Sales and Marketing MA, Roche
Roche has launched a renewed bid to buy out Genentech, making a 'hostile' bid for the company by appealing directly …
RoActemra approved in Europe
January 29, 2009Sales and Marketing RoActemra, Roche
The European Commission has approved Roche's RoActemra as a treatment for rheumatoid arthritis. Schering-Plough's Remicade, Wyeth's Enbrel and Abbott's Humira …
Roche to cut 780 production jobs
January 21, 2009Manufacturing and Production Roche, restructure
Roche will shed 780 production jobs over the next two years as it continues to streamline its manufacturing operations, but …
Roche celebrates 100 years in the UK
January 21, 2009Sales and Marketing Roche
Roche has marked the centenary of the opening of its UK office by raising £20,000 for a local charity. To …
New Pegasys licence gives patients ‘second chance for a cure’
December 4, 2008Sales and Marketing Roche, hepatitis
Hepatitis C patients who don't at first respond to treatment with Pegasys will now be able to receive the drug …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
